Ammunition Life Technology Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • IPO Registration

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 7

Ammunition Life Technology General Information

Description

Developer of early cancer screening technology focusing on colorectal cancer, cervical cancer, esophageal cancer, endometrial cancer. The company researches and develops early cancer detection products by utilizing epigenetics, nanomaterials, bioinformatics, big data technology and artificial intelligence analysis, enabling doctors to detect, diagnose and treat early cancer accurately.

Contact Information

Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Building B10, High-Tech Medical Device Park
  • No.818 Gaoxin Avenue, Donghu High-tech Development Zone
  • Wuhan, Hubei 430200
  • China
+86 027
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Corporate Office
  • Building B10, High-Tech Medical Device Park
  • No.818 Gaoxin Avenue, Donghu High-tech Development Zone
  • Wuhan, Hubei 430200
  • China
+86 027

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ammunition Life Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. IPO 29-Sep-2025 Announced Generating Revenue
5. Later Stage VC (Series C) 28-Apr-2022 Completed Generating Revenue
4. Later Stage VC (Series B) 02-Feb-2021 Completed Generating Revenue
3. Early Stage VC (Series A) 27-Apr-2020 Completed Generating Revenue
2. Early Stage VC 27-Jan-2018 $2.17M $2.17M Completed Generating Revenue
1. Early Stage VC 11-Nov-2016 Completed Startup
To view Ammunition Life Technology’s complete valuation and funding history, request access »

Ammunition Life Technology Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Wuhan Hi-Tech Government Minority
Changjiang Securities Innovation Investment Corporate Venture Capital Minority
Jinhe Capital Growth/Expansion Minority
CCB International PE/Buyout Minority
Guangdong Hybribio Biotech Company Corporation Minority
You’re viewing 5 of 7 investors. Get the full list »

Ammunition Life Technology FAQs

  • When was Ammunition Life Technology founded?

    Ammunition Life Technology was founded in 2015.

  • Where is Ammunition Life Technology headquartered?

    Ammunition Life Technology is headquartered in Wuhan, China.

  • What industry is Ammunition Life Technology in?

    Ammunition Life Technology’s primary industry is Diagnostic Equipment.

  • Is Ammunition Life Technology a private or public company?

    Ammunition Life Technology is a Private company.

  • What is Ammunition Life Technology’s current revenue?

    The current revenue for Ammunition Life Technology is .

  • How much funding has Ammunition Life Technology raised over time?

    Ammunition Life Technology has raised $33.2M.

  • Who are Ammunition Life Technology’s investors?

    Wuhan Hi-Tech, Changjiang Securities Innovation Investment, Jinhe Capital, CCB International, and Guangdong Hybribio Biotech Company are 5 of 7 investors who have invested in Ammunition Life Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process